Sino Biological,Inc. (SHE:301047)

China flag China · Delayed Price · Currency is CNY
76.86
-0.85 (-1.09%)
At close: Jan 22, 2026
28.70%
Market Cap9.35B
Revenue (ttm)660.17M
Net Income (ttm)132.79M
Shares Out121.64M
EPS (ttm)1.08
PE Ratio71.49
Forward PE66.55
Dividend4.00 (5.15%)
Ex-Dividend DateSep 22, 2025
Volume1,073,220
Average Volume1,642,799
Open77.71
Previous Close77.71
Day's Range76.66 - 77.77
52-Week Range57.40 - 85.00
Beta1.01
RSI62.03
Earnings DateApr 14, 2026

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine dev... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 1,021
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301047
Full Company Profile

Financial Performance

In 2024, Sino Biological,Inc.'s revenue was 613.67 million, a decrease of -5.06% compared to the previous year's 646.39 million. Earnings were 121.93 million, a decrease of -53.13%.

Financial Statements